EdgeMarket › What Tpg Gp A, Llc reported owning
What Tpg Gp A, Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
3.7BPositions
76Quarter
2026-03-31Shown below
50largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| LFST LifeStance Health Group, Inc. | 892.0M | 24.2% | 140.0M | 12.47 | +133.1% |
| JXN Jackson Financial Inc. | 498.5M | 13.6% | 4.7M | 129.88 | +34.9% |
| LTH Life Time Group Holdings, Inc. | 480.4M | 13.1% | 17.8M | 45.11 | +60.7% |
| SION Sionna Therapeutics, Inc. | 260.4M | 7.1% | 6.5M | 5.29 | -76.8% |
| BETA BETA Technologies, Inc. | 241.0M | 6.6% | 16.4M | 24.74 | — |
| AMRX Amneal Pharmaceuticals, Inc. | 153.2M | 4.2% | 12.3M | 17.91 | +90.3% |
| NGL NGL Energy Partners LP | 73.2M | 2.0% | 5.9M | 16.81 | +242.4% |
| CBLL Ceribell, Inc. | 72.7M | 2.0% | 4.0M | 24.20 | +109.0% |
| NVRI Enviri Corp | 70.9M | 1.9% | 3.6M | 20.65 | +99.7% |
| unmapped CUSIP 09709UV70 | 67.7M | 1.8% | 56.6M | — | — |
| BCAX Bicara Therapeutics Inc. | 59.9M | 1.6% | 3.0M | 23.90 | +118.1% |
| unmapped CUSIP 30034WAD8 | 54.0M | 1.5% | 40.0M | — | — |
| unmapped CUSIP 85571BBA2 | 47.0M | 1.3% | 46.2M | — | — |
| BRKRP BRUKER CORP | 47.0M | 1.3% | 163.0K | 439.40 | — |
| ALLO Allogene Therapeutics, Inc. | 45.7M | 1.2% | 18.7M | 2.09 | +97.2% |
| unmapped CUSIP 69331CAL2 | 44.5M | 1.2% | 43.0M | — | — |
| unmapped CUSIP 92939UAR7 | 42.1M | 1.1% | 34.0M | — | — |
| unmapped CUSIP 42824C208 | 37.3M | 1.0% | 575.0K | — | — |
| NX Quanex Building Products CORP | 36.9M | 1.0% | 2.1M | 20.28 | -3.2% |
| NOVTU NOVANTA INC | 35.4M | 1.0% | 661.7K | 62.26 | — |
| unmapped CUSIP 57164YAF4 | 29.8M | 0.8% | 31.0M | — | — |
| unmapped CUSIP 69331C306 | 29.3M | 0.8% | 680.0K | — | — |
| unmapped CUSIP 65339F655 | 28.8M | 0.8% | 575.0K | — | — |
| unmapped CUSIP 723484AK7 | 28.6M | 0.8% | 25.0M | — | — |
| unmapped CUSIP 10316TAD6 | 26.6M | 0.7% | 29.0M | — | — |
| unmapped CUSIP 501812AD3 | 25.2M | 0.7% | 21.0M | — | — |
| unmapped CUSIP 03769M304 | 19.1M | 0.5% | 325.0K | — | — |
| PPLC PPL Corp | 18.9M | 0.5% | 370.0K | 46.13 | +53.4% |
| TRTX TPG RE Finance Trust, Inc. | 18.7M | 0.5% | 2.4M | 7.89 | -14.0% |
| unmapped CUSIP 03990B309 | 15.5M | 0.4% | 419.5K | — | — |
| EA ELECTRONIC ARTS INC. | 13.3M | 0.4% | 65.0K | 209.70 | +33.5% |
| unmapped CUSIP 69352PAS2 | 12.3M | 0.3% | 10.5M | — | — |
| NSC NORFOLK SOUTHERN CORP | 11.5M | 0.3% | 40.0K | 350.72 | +22.8% |
| unmapped CUSIP 40637HAD1 | 10.4M | 0.3% | 10.0M | — | — |
| unmapped CUSIP 68389X204 | 10.3M | 0.3% | 225.0K | — | — |
| unmapped CUSIP 185123106 | 9.1M | 0.2% | 385.0K | — | — |
| unmapped CUSIP 53802LAB8 | 8.7M | 0.2% | 7.5M | — | — |
| MCHPP MICROCHIP TECHNOLOGY INC | 8.5M | 0.2% | 150.0K | 65.86 | +7.2% |
| WBD Warner Bros. Discovery, Inc. | 8.1M | 0.2% | 295.0K | 28.55 | +147.4% |
| unmapped CUSIP 68278B107 | 7.8M | 0.2% | 325.0K | — | — |
| unmapped CUSIP 163072AC5 | 7.1M | 0.2% | 7.0M | — | — |
| unmapped CUSIP 963320205 | 7.0M | 0.2% | 170.0K | — | — |
| PEN Penumbra Inc | 6.6M | 0.2% | 20.0K | 325.18 | +27.2% |
| unmapped CUSIP 16115Q308 | 6.2M | 0.2% | 30.0K | — | — |
| unmapped CUSIP 125896BX7 | 5.7M | 0.2% | 5.0M | — | — |
| KVUE Kenvue Inc. | 5.2M | 0.1% | 300.0K | 19.06 | -11.9% |
| unmapped CUSIP 67059NAK4 | 4.5M | 0.1% | 5.0M | — | — |
| unmapped CUSIP 574795100 | 4.4M | 0.1% | 25.0K | — | — |
| unmapped CUSIP 090043AF7 | 4.4M | 0.1% | 5.0M | — | — |
| unmapped CUSIP 29786AAN6 | 4.2M | 0.1% | 4.7M | — | — |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →